Shares of Amarillo Biosciences, Inc. (OTCMKTS:AMAR – Get Free Report) traded down 14.3% during mid-day trading on Monday . The stock traded as low as $0.60 and last traded at $0.60. 6,100 shares traded hands during trading, a decline of 67% from the average session volume of 18,253 shares. The stock had previously closed at $0.70.
Amarillo Biosciences Stock Down 14.3 %
The firm’s 50-day moving average price is $0.60.
About Amarillo Biosciences
Amarillo Biosciences, Inc, a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases.
See Also
- Five stocks we like better than Amarillo Biosciences
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Value Stocks You Can Buy Before They Become Big
- 3 Tickers Leading a Meme Stock Revival
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Amarillo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
